Acta Psychiatrica Scandinavica

A successful antipsychotic combination trial. Quo Vadis?
pp. 241-242(2)
Authors: Stephen Stahl; Oliver Freudenreich; Donald Goff

Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies
pp. 243-256(14)
Authors: K. Hill; L. Mann; K. R. Laws; C. M. E. Stephenson; I. Nimmo-Smith; P. J. McKenna

Poor maternal care and high maternal body mass index in pregnancy as a risk factor for schizophrenia in offspring
pp. 257-263(7)
Authors: M. Kawai; Y. Minabe; S. Takagai; M. Ogai; H. Matsumoto; N. Mori; N. Takei

Hallucinatory experiences and onset of psychotic disorder: evidence that the risk is mediated by delusion formation
pp. 264-272(9)
Authors: L. Krabbendam; I. Myin-Germeys; M. Hanssen; R. V. Bijl; R. de Graaf; W. Vollebergh; M. Bak; J. van Os

Pleasurable auditory hallucinations
pp. 273-278(6)
Authors: J. Sanjuan; J. C. Gonzalez; E. J. Aguilar; C. Leal; J. Os

Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey
pp. 279-285(7)
Authors: K. Saari; J. Jokelainen; J. Veijola; H. Koponen; P.B. Jones; M. Savolainen; M.-R. Järvelin; L. Lauren; M. Isohanni; S. Lindeman

Does duration of untreated psychosis bias study samples of first-episode psychosis?
pp. 286-291(6)
Authors: S. Friis; I. Melle; T. K. Larsen; U. Haahr; J. O. Johannessen; E. Simonsen; S. Opjordsmoen; P. Vaglum; T. H. McGlashan

Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine
pp. 292-298(7)
Authors: J. Munro; P. Matthiasson; S. Osborne; M. Travis; S. Purcell; A. M. Cobb; M. Launer; M. D. Beer; R. Kerwin

Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs
pp. 299-305(7)
Authors: C. Paton; R. Esop; C. Young; D. Taylor

The dental health of people with schizophrenia
pp. 306-310(5)
Authors: R. G. McCreadie; H. Stevens; J. Henderson; D. Hall; R. McCaul; R. Filik; G. Young; G. Sutch; G. Kanagaratnam; S. Perrington; J. McKendrick; D. Stephenson; T. Burns

On the threshold of subthreshold depression
pp. 311-311(1)
Author: S.K. Chaturvedi

Reply:
pp. 311-312(2)
Author: Pim Cuijpers

Amphetamine-like stimulant cessation in an abusing patient treated with buproprion (Tardiev et al. 2004)
pp. 312-312(1)
Author: Timothy Berigan

Reply
pp. 312-312(1)
Author: Olivier Blin

Books received (selected titles)
pp. 313-314(2)
Authors: Povl Munk-Jørgensen

Suicide in children and adolescents
pp. 315-315(1)
Authors: Rita Berghammer; Agnes Hajnal

Advancement in the management and treatment of depression
pp. 315-315(1)
Author: Klaus Martiny

Disorders of brain and mind 2
pp. 315-316(2)
Author: Machteld Marcelis

Campbell's psychiatric dictionary
pp. 316-316(1)
Authors: Povl Munk-Jørgensen

Autism and creativity. Is there a link between autism and exceptional ability
pp. 316-316(1)
Author: Marlene B. Lauritsen

Beating the blues: new approaches to overcoming dysthymia and chronic mild depression
pp. 316-317(2)
Author: Pim Cuijpers

Models of madness
pp. 317-317(1)
Author: TJ Crow

Dopamine in the pathophysiology and treatment of schizophrenia: New findings
pp. 317-317(1)
Authors: Birte Glenthøj

The self in neuroscience and psychiatry
pp. 318-318(1)
Author: Raben Rosenberg

Cultural diversity, mental health and psychiatry: the struggle against racism
pp. 318-318(1)
Author: Dinesh Bhugra

Biographies
pp. 319-320(2)
Authors: Povl Munk-Jørgensen